ESR1 and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC) accounts for 10–15% of breast cancer cases and is a subtype characterized by the lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression/amplification [1].